losartan-potassium and Lupus-Erythematosus--Cutaneous

losartan-potassium has been researched along with Lupus-Erythematosus--Cutaneous* in 1 studies

Other Studies

1 other study(ies) available for losartan-potassium and Lupus-Erythematosus--Cutaneous

ArticleYear
[Paclitaxel-induced lupus].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:9 Pt 1

    Paclitaxel (Taxol) is a drug derived from the bark of the Pacific yew tree and is widely used in cancer treatment, especially for breast, ovarian, and lung cancers. It has not previously been reported to induce lupus.. We report the case of a woman with ovarian cancer who developed paclitaxel-induced lupus on two occasions. Both times, the paclitaxel dramatically improved the ovarian cancer.. The diagnosis of lupus was confirmed by the initial skin appearance, elevated levels of antinuclear antibodies, recurrence on reintroduction, and biopsy results. To our knowledge, it is the first case reported of paclitaxel-induced lupus.

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Betamethasone; Biopsy; Drug Therapy, Combination; Erythropoietin; Female; Humans; Lupus Erythematosus, Cutaneous; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Recurrence; Skin; Treatment Outcome

2007